Business Context and Reporting Period
Company: Intrusion, Inc. (INTZ)
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2026
Reporting Period: The filing covers a warrant inducement program conducted from August 17, 2026, through August 28, 2026.
Key Financial Metrics
This filing reports on a specific capital raise event rather than full-period financial statements. Key metrics related to the transaction include:
- Cash Proceeds: $1,320,458 raised from warrant exercises.
- Shares Issued: 1,660,954 shares of common stock issued upon exercise of existing warrants.
- Exercise Price: $0.795 per share (temporarily reduced price for existing warrants).
- New Warrants Issued: 1,660,954 new warrants issued in connection with the exercises.
- New Warrant Terms: Exercise price of $0.67; five-year exercise period.
Note: The filing text does not provide clear values for total revenue, net profit, operating margins, total debt, or overall liquidity positions outside of the proceeds from this specific transaction.
Material Changes
The primary material change is the increase in outstanding common stock and the issuance of new warrants resulting from the inducement program. The company successfully converted 1,660,954 existing warrants into cash and equity, altering its capital structure.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors approved the warrant inducement program to encourage holders to exercise outstanding warrants at a reduced price. The program was executed as planned within the specified window.
Regulatory Context: The offering of shares and new warrants was undertaken pursuant to the exemption from registration provided in Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506(b) under Regulation D.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard implications of equity dilution and the terms of the new warrants.
Investor Verification Checklist
- Verify the total number of outstanding shares post-transaction to assess dilution impact.
- Confirm the total number of outstanding warrants following the issuance of 1,660,954 new warrants.
- Review the company's cash balance to confirm the $1,320,458 in proceeds has been received and allocated.
- Check subsequent filings for any updates on the exercise of the remaining outstanding warrants not covered by this inducement.